Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Routine pneumococcal vaccination of children provokes new patterns of serotypes causing invasive pneumococcal disease in adults and children.

Norton NB, Stanek RJ, Mufson MA.

Am J Med Sci. 2013 Feb;345(2):112-20. doi: 10.1097/MAJ.0b013e3182517785.

PMID:
22814362
2.

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.

Vaccine. 2013 Dec 16;31(52):6232-8. doi: 10.1016/j.vaccine.2013.10.032. Epub 2013 Oct 29.

PMID:
24176490
3.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

PMID:
18627249
4.

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.

Lepoutre A, Varon E, Georges S, Dorléans F, Janoir C, Gutmann L, Lévy-Bruhl D; Microbiologists of Epibac.; ORP Networks..

Vaccine. 2015 Jan 3;33(2):359-66. doi: 10.1016/j.vaccine.2014.11.011. Epub 2014 Nov 20.

PMID:
25448105
5.

Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee.

Halasa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W.

Pediatr Infect Dis J. 2013 Jun;32(6):604-9. doi: 10.1097/INF.0b013e318287fe0d.

PMID:
23348816
6.

Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.

Lamb KE, Flasche S, Diggle M, Inverarity D, Greenhalgh D, Jefferies JM, Smith A, Edwards GF, Denham B, McMenamin J, McDonald E, Mitchell TJ, Clarke SC, Robertson C.

Vaccine. 2014 Jul 23;32(34):4356-63. doi: 10.1016/j.vaccine.2013.05.079. Epub 2013 Jun 24.

7.

Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.

Rudnick W, Liu Z, Shigayeva A, Low DE, Green K, Plevneshi A, Devlin R, Downey J, Katz K, Kitai I, Krajden S, Ostrowska K, Richardson D, Richardson S, Sarabia A, Silverman M, Simor AE, Tyrrell G, McGeer A; Toronto Invasive Bacterial Diseases Network..

Vaccine. 2013 Dec 2;31(49):5863-71. doi: 10.1016/j.vaccine.2013.09.049. Epub 2013 Oct 5.

PMID:
24099873
8.

Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine.

Suga S, Chang B, Asada K, Akeda H, Nishi J, Okada K, Wakiguchi H, Maeda A, Oda M, Ishiwada N, Saitoh A, Oishi T, Hosoya M, Togashi T, Oishi K, Ihara T.

Vaccine. 2015 Nov 9;33(45):6054-60. doi: 10.1016/j.vaccine.2015.07.069. Epub 2015 Jul 31.

PMID:
26235372
9.

Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain.

Guevara M, Barricarte A, Gil-Setas A, García-Irure JJ, Beristain X, Torroba L, Petit A, Polo Vigas ME, Aguinaga A, Castilla J.

Clin Microbiol Infect. 2009 Nov;15(11):1013-9. doi: 10.1111/j.1469-0691.2009.02904.x. Epub 2009 Aug 7.

10.

Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.

van der Linden M, Falkenhorst G, Perniciaro S, Imöhl M.

PLoS One. 2015 Jul 1;10(7):e0131494. doi: 10.1371/journal.pone.0131494. eCollection 2015.

11.

Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.

Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW.

Clin Infect Dis. 2009 Jul 15;49(2):205-12. doi: 10.1086/599827.

PMID:
19508165
12.
14.

Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).

American Academy of Pediatrics Committee on Infectious Diseases..

Pediatrics. 2010 Jul;126(1):186-90. doi: 10.1542/peds.2010-1280. Epub 2010 May 24.

PMID:
20498180
15.

Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden.

Galanis I, Lindstrand A, Darenberg J, Browall S, Nannapaneni P, Sjöström K, Morfeldt E, Naucler P, Blennow M, Örtqvist Å, Henriques-Normark B.

Eur Respir J. 2016 Apr;47(4):1208-18. doi: 10.1183/13993003.01451-2015. Epub 2016 Jan 21.

16.

Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta.

Leal J, Vanderkooi OG, Church DL, Macdonald J, Tyrrell GJ, Kellner JD.

Pediatr Infect Dis J. 2012 Sep;31(9):e169-75.

PMID:
22673137
17.

Have changing pneumococcal vaccination programmes impacted disease in Ontario?

Lim GH, Wormsbecker AE, McGeer A, Pillai DR, Gubbay JB, Rudnick W, Low DE, Green K, Crowcroft NS, Deeks SL.

Vaccine. 2013 May 31;31(24):2680-5. doi: 10.1016/j.vaccine.2013.04.007. Epub 2013 Apr 16.

PMID:
23597716
18.

Streptococcus pneumoniae Serotypes Identified in Mexican Children with Invasive Disease Before and After the Introduction of PCV7 (1993-2012).

Echaniz-Aviles G, Soto-Nogueron A, Miranda-Novales G, Carnalla-Barajas MN, Velazquez-Meza ME, Solórzano-Santos F; SIREVA Network–Mexico..

Arch Med Res. 2015 Feb;46(2):149-53. doi: 10.1016/j.arcmed.2015.02.004. Epub 2015 Mar 2.

PMID:
25743930
19.

Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.

Olarte L, Ampofo K, Stockmann C, Mason EO, Daly JA, Pavia AT, Byington CL.

Pediatrics. 2013 Jul;132(1):e17-24. doi: 10.1542/peds.2012-3900. Epub 2013 Jun 3.

20.

Supplemental Content

Support Center